Monash IVF Group Limited (ASX: MVF) unveiled impressive results for the fiscal year ending 30 June 2024. During this period, all three of Monash IVF's business segments - Domestic IVF, Women's Imaging, and International ARS - achieved substantial revenue and earnings growth. Notably, there has been significant volume growth across its SE Asia clinics, particularly in 2H24. Revenue skyrocketed by 19.4% to AU$255.0 million, while the underlying Group NPAT surged by 17.4% to AU$29.9 million. The underlying Group EBITDA also grew by 17.5% to AU$62.8 million. Furthermore, it successfully maintained the EBITDA margin at 25%.
The company achieved a second consecutive year of double-digit revenue and underlying earnings growth amidst persistent cost-of-living and inflationary pressures. This is a testament to the indispensable nature of IVF and ultrasound services and the strategic advantage of its geographic diversification across Australia and SE Asia.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 20, 2024
Nov 20, 2024
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
